alpha-aminopyridine has been researched along with Menopause in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamo, B; Bellet, M; Brasó-Maristany, F; Carey, LA; Chic, N; Ciruelos, E; Cortés, J; Galván, P; Gavilá, J; González-Farré, B; Martínez, D; Martínez-Sáez, O; Muñoz, M; Oliveira, M; Pascual, T; Pernas, S; Perou, CM; Prat, A; Sanfeliu, E; Saura, C; Schettini, F; Soberino, J; Vidal, M | 1 |
1 trial(s) available for alpha-aminopyridine and Menopause
| Article | Year |
|---|---|
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; MCF-7 Cells; Menopause; Middle Aged; Neoadjuvant Therapy; Purines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Transcriptome | 2021 |